Salvage Chemotherapy in Recurrent Cervical Cancer With Biweekly Pegylated Liposomal Doxorubicin (Lipo-Dox)

• Main Authors: Jen-Ruei Chen (Author), Yuh-Cheng Yang (Author), Tze-Chien Chen (Author), Jerry Cheng-Yen Lai (Author), Shing-Jyh Chang (Author), Chi-Long Chang (Author), Kung-Liahng Wang (Author)
• Format: Book
• Published: Elsevier, 2008-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: To investigate the objective response rate to and tolerance of biweekly Lipo-Dox (TTY Biopharm Co. Ltd., Taipei, Taiwan) at a dosage of 20 mg/m2 in previously treated patients with recurrent cervical cancer. Materials and Methods: This study was performed as a Simon's two-stage phase...